Toby C. Trujillo PharmD, FCCP, FAHA, BCPS-AQ CardiologyAssociate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; Clinical Specialist - Anticoagulation/Cardiology, Co-Chair, Anticoagulation Subcommittee UC Health, University of Colorado Hospital, Aurora, Colorado
Dr. Toby Trujillo, PharmD, FCCP, FAHA, BCPS-AQ Cardiology, is an Associate Professor of Clinical Pharmacy at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado. He also serves as Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital. Dr. Trujillo earned his Bachelor of Science degree in biochemistry from the University of California, Davis and his Doctor of Pharmacy degree from the University of California, San Francisco, where he also completed a residency in pharmacy practice. Dr. Trujillo completed a fellowship in cardiovascular pharmacotherapy at The University of Arizona, and he is a board-certified pharmacotherapy specialist with added qualifications in cardiology. In his current role, Dr. Trujillo is involved in the stewardship of antithrombotic medications across the UC Health System, which includes serving as co-chair of the anticoagulation subcommittee of the P&T committee, as well as coordinating and staffing the Inpatient-Anticoagulation Thrombosis Management Service. Dr. Trujillo has served in several capacities within multidisciplinary organizations such as the American Heart Association, American College of Cardiology, and the Society of Critical Care Medicine. Dr. Trujillo has also served a number of committees and leadership positions within the American College of Clinical Pharmacy including currently serving on the Board of Regents. Dr. Trujillo has served as a speaker on numerous occasions on a national and international level, and has published over 70 original research articles, review articles, and book chapters dealing with the area of cardiovascular pharmacotherapy. His research interests primarily focus on the appropriate use of antithrombotic medications, both at the patient and health-system level.